Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annelies Colliers

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
BJGP Open|December 18, 2021
Point-of-care testing, antibiotic prescribing, and prescribing confidence for respiratory tract infections in primary care: a prospective audit in 18 European countriesAlike W van der Velden, Alma C van de Pol, Emily Bongard, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 6, 2022
Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial dataTheo J Verheij, Daniela Cianci, Alike W van der Velden, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 21, 2022
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC<sup>4</sup>E trial in 15 European countriesXiao Li, Joke Bilcke, Alike W van der Velden, et al.
BMJ Open|July 14, 2018
Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC<sup>4</sup> E): the ALIC<sup>4</sup> E protocolEmily Bongard, Alike W van der Velden, Johanna Cook, et al.
Lancet (London, England)|December 17, 2019
Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trialChristopher C Butler, Alike W van der Velden, Emily Bongard, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
BJGP Open|December 18, 2021
Point-of-care testing, antibiotic prescribing, and prescribing confidence for respiratory tract infections in primary care: a prospective audit in 18 European countriesAlike W van der Velden, Alma C van de Pol, Emily Bongard, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 6, 2022
Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial dataTheo J Verheij, Daniela Cianci, Alike W van der Velden, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 21, 2022
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC<sup>4</sup>E trial in 15 European countriesXiao Li, Joke Bilcke, Alike W van der Velden, et al.
BMJ Open|July 14, 2018
Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC<sup>4</sup> E): the ALIC<sup>4</sup> E protocolEmily Bongard, Alike W van der Velden, Johanna Cook, et al.
Lancet (London, England)|December 17, 2019
Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trialChristopher C Butler, Alike W van der Velden, Emily Bongard, et al.
Pageof 4